Macrogen has been a leader in precision medicine and biotechnology, serving more than 18,000 customers from academic research and industry in 153 countries. We envision data-driven precision medicine that predicts, diagnoses, and treats diseases by integrating genetic data into health records. We provide a range of high-quality DNA sequencing service (NGS, CES), COVID-19 test kits and on-site testing lab, and personal health offerings based on personal genome sequencing and gut microbiome test. Headquartered in South Korea, we have overseas subsidiaries and branches in the United States(Psomagen), Japan, Europe, Singapore, and Spain.